31基因表达谱联合AJCC在线工具可更准确识别高危皮肤黑色素瘤
本研究比较31基因表达谱(GEP)与AJCC在线个体化黑色素瘤预后预测工具联合使用的准确性。对205例I/II期皮肤黑色素瘤分析发现,两种工具均能显著分类无远处转移生存和总生存,但GEP与AJCC(79%截断值)分类不一致时,GEP预测高危而AJCC预测低危的患者占多数死亡。结论认为GEP联合AJCC在线工具可提供有价值预后信息并改善高危黑色素瘤识别。
要点
- GEP与AJCC在线工具联合可提高高危黑色素瘤识别准确性
- GEP和AJCC工具对无远处转移生存和总生存均有显著风险分层
- 两工具分类不一致时,GEP高危预测更准确识别死亡风险
核心结论
- GEP联合AJCC在线预测工具可提供有价值预后信息并改善高危黑色素瘤识别。
研究设计与样本
- 回顾性分析205例I/II期皮肤黑色素瘤的GEP结果,并以AJCC在线工具进行预后评估。
主要发现
- Cox单因素分析显示GEP和AJCC工具对无远处转移生存和总生存均有显著风险分类(风险比范围3.2-9.4,P < .001)。
- 43例(21%)GEP与AJCC分类不一致(采用79%截断值)。
关键数值与推荐
- 采用两个5年总生存截断值(AJCC 79%和68%)分别对应IIA期和IIB期患者的生存。
临床怎么用
- 临床可联合使用GEP与AJCC在线工具以更准确识别高危早期黑色素瘤患者。
局限性
- 标本来源于三级医疗中心转诊患者。
- 更有效疗法在入组后已获批临床使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A significant proportion of patients with American Joint Committee on Cancer (AJCC)-defined early-stage cutaneous melanoma have disease recurrence and die. A 31-gene expression profile (GEP) that accurately assesses metastatic risk associated with primary cutaneous melanomas has been described. OBJECTIVE: We sought to compare accuracy of the GEP in combination with risk determined using the web-based AJCC Individualized Melanoma Patient Outcome Prediction Tool. METHODS: GEP results from 205 stage I/II cutaneous melanomas with sufficient clinical data for prognostication using the AJCC tool were classified as low (class 1) or high (class 2) risk. Two 5-year overall survival cutoffs (AJCC 79% and 68%), reflecting survival for patients with stage IIA or IIB disease, respectively, were assigned for binary AJCC risk. RESULTS: Cox univariate analysis revealed significant risk classification of distant metastasis-free and overall survival (hazard ratio range 3.2-9.4, P < .001) for both tools. In all, 43 (21%) cases had discordant GEP and AJCC classification (using 79% cutoff). Eleven of 13 (85%) deaths in that group were predicted as high risk by GEP but low risk by AJCC. LIMITATIONS: Specimens reflect tertiary care center referrals; more effective therapies have been approved for clinical use after accrual. CONCLUSIONS: The GEP provides valuable prognostic information and improves identification of high-risk melanomas when used together with the AJCC online prediction tool.
引用
- Ferris LK, Farberg AS, Middlebrook B, et al. Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31-gene expression profile-based classification. J Am Acad Dermatol. 2017. PMID: 28110997. doi:10.1016/j.jaad.2016.11.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。